Table 2.
Regression analysis showing associated factors for TB/HIV co-infection, Northeastern Amhara, Ethiopia, 2015
| Predictor variables | TB–HIV confection | COR (95 % CI), P value | AOR (95 % CI), P value | ||
|---|---|---|---|---|---|
| Yes N (%) | No N (%) | Total N | |||
| Sex | |||||
| Female | 113 (25.7) | 326 (74.3) | 439 | 1.2 (0.9–1.6), 0.2 | 1.2 (0.9–1.6), 0.17 |
| Male | 123 (22.3) | 428 (77.7) | 551 | 1 | |
| Age | |||||
| ≤24 | 44 (13.5) | 282 (86.5) | 326 | 0.9 (0.57–1.6), 0.85 | 0.9 (0.57–1.6), 0.85 |
| 25–45 | 163 (29.4) | 295 (70.6) | 418 | 3.4 (2–5), 0.00 | 3.4 (2–5), 0.00 |
| ≥46 | 29 (14.1) | 177 (85.9) | 206 | 1 | 1 |
| Types of TB | |||||
| PTB+ | 71 (36.2) | 125 (63.8) | 196 | 2.8 (1.9–4), 0.00 | 2.2 (1.4–3.3), 0.00 |
| PTB− | 87 (26.2) | 245 (73.8) | 332 | 1.7 (1.2–2.5), 0.002 | 1.9 (1.3–2.8), 001 |
| EPTB | 78 (16.9) | 384 (83.1) | 462 | 1 | 1 |
| TB treatment outcome | |||||
| Unknown | 4 (36.4) | 7 (63.6) | 11 | 2 (0.58–6.98), 0.26 | 2 (0.56–7.3), 0.23 |
| Transfer out | 5 (16.7) | 25 (83.3) | 30 | 0.7 (0.26–1.8), 0.48 | 0.64 (0.23–1.75), 0.38 |
| Poor | 39 (40.6) | 57 (59.4) | 96 | 2.4 (1.56–3.75), 0.00 | 2 (1.2–3.1), 0.003 |
| Success | 188 (22) | 665 (78) | 853 | 1 | 1 |
AOR adjusted odds ratio, ART antiretroviral therapy, COR crude odds ratio, CPT co-trimoxazole preventive therapy, EPTB extra pulmonary TB, HIV human immunodeficiency virus, PTB− smears negative pulmonary TB, PTB+ smear-positive pulmonary TB, TB tuberculosis